WASHINGTON (MedPage Today) -- The FDA has updated labels of the HIV drug didanosine (Videx and Videx EC) to include warnings for potentially serious liver damage.
FDA Revises HIV Drug Label for Liver ComplicationCourtesy MedPage Today Infectious Disease Sun, 01/31/2010 - 17:00
WASHINGTON (MedPage Today) -- The FDA has updated labels of the HIV drug didanosine (Videx and Videx EC) to include warnings for potentially serious liver damage. More related itemsICAAC: New Drug Easier to Take than HIV Standard...
Untreated HIV Patients Have New Drug Option (CME/CE)
ACTHIV: Etravirine Better in Less Treated Patients...
Alcohawk Precision Digital Alcohol Breath Tester
Genuine Magnetrainer ER (Extended Range) Mini...
|
Popular by tags WeekMonth |
Post new comment